Bioactive Compounds
-
BA1859 PeretinoinSummary: Peretinoin is an orally administered non-cyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors, such as and ... - BA1858 GSK-A1Summary: GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA inhibitor.
- BA1857 EIDD-2749Summary: EIDD-2749 (4'-Fluorouridine) is an orally effective inhibitor.
- BA1856 OmbitasvirSummary: Ombitasvir is an inhibitor.
- BA1855 AlisporivirSummary: Alisporivir (Debio-025) is a procyclin inhibitor.
- BA1854 DaclatasvirSummary: Daclatasvir (BMS-790052) is a potent orally active protein inhibitor with multiple replicon genotypes ranging from 9-146 pM.
- BA1853 BLT-1Summary: BLT-1 is a copper thiosemicarbazone chelator and selective scavenger receptor type B1 inhibitor.
- BA1851 PibrentasvirSummary: Pibrentasvir is a novel pan-genotypic hepatitis C virus inhibitor.
- BA1850 LagociclovirSummary: Lagociclovir (FLG) is a nucleoside analog.
- BA1849 HBV-IN-37Summary: HBV-IN-37 is an inhibitor.